356 related articles for article (PubMed ID: 31454891)
41. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans.
Diaz R; Ghofaily LA; Patel J; Balashova NV; Freitas AC; Labib I; Kachlany SC
Microb Pathog; 2006 Feb; 40(2):48-55. PubMed ID: 16414241
[TBL] [Abstract][Full Text] [Related]
42. Mlc is a transcriptional activator with a key role in integrating cyclic AMP receptor protein and integration host factor regulation of leukotoxin RNA synthesis in Aggregatibacter actinomycetemcomitans.
Childress C; Feuerbacher LA; Phillips L; Burgum A; Kolodrubetz D
J Bacteriol; 2013 May; 195(10):2284-97. PubMed ID: 23475968
[TBL] [Abstract][Full Text] [Related]
43. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.
Balashova NV; Shah C; Patel JK; Megalla S; Kachlany SC
Gene; 2009 Aug; 443(1-2):42-7. PubMed ID: 19450669
[TBL] [Abstract][Full Text] [Related]
44. Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans.
Kachlany SC; Fine DH; Figurski DH
Protein Expr Purif; 2002 Aug; 25(3):465-71. PubMed ID: 12182827
[TBL] [Abstract][Full Text] [Related]
45. Membrane association and destabilization by Aggregatibacter actinomycetemcomitans leukotoxin requires changes in secondary structures.
Walters MJ; Brown AC; Edrington TC; Baranwal S; Du Y; Lally ET; Boesze-Battaglia K
Mol Oral Microbiol; 2013 Oct; 28(5):342-53. PubMed ID: 23678967
[TBL] [Abstract][Full Text] [Related]
46. Catechin-mediated restructuring of a bacterial toxin inhibits activity.
Chang EH; Huang J; Lin Z; Brown AC
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):191-198. PubMed ID: 30342156
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of LtxA (Leukotoxin), a Potent New Anti-Inflammatory Agent for the Treatment of Alopecia Areata.
Kachlany SC
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):19-22. PubMed ID: 26551939
[TBL] [Abstract][Full Text] [Related]
48. In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
Gupta A; Le A; Belinka BA; Kachlany SC
Leuk Res; 2011 Nov; 35(11):1498-505. PubMed ID: 21664691
[TBL] [Abstract][Full Text] [Related]
49.
Looh SC; Soo ZMP; Wong JJ; Yam HC; Chow SK; Hwang JS
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051027
[TBL] [Abstract][Full Text] [Related]
50. Solving the riddle: Unraveling the mechanisms of blocking the binding of leukotoxin by therapeutic antagonists in periodontal diseases.
Abdullahi M; Olotu FA; Soliman ME
J Cell Biochem; 2018 Nov; 119(11):9364-9379. PubMed ID: 30129224
[TBL] [Abstract][Full Text] [Related]
51. Expression and targeting of lymphocyte function-associated antigen 1 (LFA-1) on white blood cells for treatment of allergic asthma.
Gupta A; Espinosa V; Galusha LE; Rahimian V; Miro KL; Rivera-Medina A; Kasinathan C; Capitle E; Aguila HA; Kachlany SC
J Leukoc Biol; 2015 Mar; 97(3):439-46. PubMed ID: 25341726
[TBL] [Abstract][Full Text] [Related]
52. Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans.
Murakami Y; Xu T; Helmerhorst EJ; Ori G; Troxler RF; Lally ET; Oppenheim FG
Oral Microbiol Immunol; 2002 Jun; 17(3):143-9. PubMed ID: 12030965
[TBL] [Abstract][Full Text] [Related]
53. Toxin-triggered liposomes for the controlled release of antibiotics to treat infections associated with the gram-negative bacterium, Aggregatibacter actinomycetemcomitans.
Li Z; Baidoun R; Brown AC
Colloids Surf B Biointerfaces; 2024 Jun; 238():113870. PubMed ID: 38555763
[TBL] [Abstract][Full Text] [Related]
54. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes.
Munksgaard PS; Vorup-Jensen T; Reinholdt J; Söderström CM; Poulsen K; Leipziger J; Praetorius HA; Skals M
Cell Microbiol; 2012 Dec; 14(12):1904-20. PubMed ID: 22906303
[TBL] [Abstract][Full Text] [Related]
55. Screen for leukotoxin mutants in Aggregatibacter actinomycetemcomitans: genes of the phosphotransferase system are required for leukotoxin biosynthesis.
Isaza MP; Duncan MS; Kaplan JB; Kachlany SC
Infect Immun; 2008 Aug; 76(8):3561-8. PubMed ID: 18541661
[TBL] [Abstract][Full Text] [Related]
56. Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis.
Herbert BA; Novince CM; Kirkwood KL
Mol Oral Microbiol; 2016 Jun; 31(3):207-27. PubMed ID: 26197893
[TBL] [Abstract][Full Text] [Related]
57. Lipopolysaccharides mediate leukotoxin secretion in Aggregatibacter actinomycetemcomitans.
Tang G; Kawai T; Komatsuzawa H; Mintz KP
Mol Oral Microbiol; 2012 Apr; 27(2):70-82. PubMed ID: 22394466
[TBL] [Abstract][Full Text] [Related]
58. Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.
Brown AC; Boesze-Battaglia K; Du Y; Stefano FP; Kieba IR; Epand RF; Kakalis L; Yeagle PL; Epand RM; Lally ET
Cell Microbiol; 2012 Jun; 14(6):869-81. PubMed ID: 22309134
[TBL] [Abstract][Full Text] [Related]
59. Heterogeneity of Size and Toxin Distribution in
Nice JB; Collins SM; Agro SMJ; Sinani A; Moros SD; Pasch LM; Brown AC
Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535804
[No Abstract] [Full Text] [Related]
60. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.
Kelk P; Johansson A; Claesson R; Hänström L; Kalfas S
Infect Immun; 2003 Aug; 71(8):4448-55. PubMed ID: 12874324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
